Exosome Diagnostics and Therapeutics: Global Markets Forecasting to 2023

Exosome Diagnostics and Therapeutics -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023

PUNE, MAHARASHTRA, INDIA, May 22, 2018 /EINPresswire.com/ — Exosome Diagnostics and Therapeutics Industry

Description

Wiseguyreports.Com Adds “Exosome Diagnostics and Therapeutics -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database

Initially, exosome particles were considered “garbage” molecules secreted by cells. Today, many researchers are convinced that these tiny vesicles have unlimited potential in diagnostics and therapeutics, especially in oncology treatments.

By definition, exosomes are small membrane sacs/vesicles, approximately 30 to 100 nanometers (nm) in diameter, that are released by both healthy and cancerous cells. Substances from cell cytoplasm, such as genomic DNA, various RNA species, proteins and lipids are encapsulated into exosomes and shed into the extracellular environment.

Research shows that all fluids in the human body contain exosomes which can transfer cytoplasmic ingredients to other cells either locally or at distant sites. Once reaching the recipient cells, cytoplasmic ingredients can alter their biology.

Scientists believe that various biomolecules in exosomes can be profiled and, consequently, may serve as useful biomarkers for different diseases. Nucleic acids such as RNA or DNA can be isolated from exosomes and further analyzed by various techniques.

Overall, the market for the exosome approach can be divided into three main categories: diagnostics, therapeutics, and research tools and is evaluated at REDACTED (see Summary Table below), with the potential to increase to REDACTED in the next five years with a compound annual growth rate (CAGR) of REDACTED.

This report evaluates the diagnostics market affected by exosome research and further potential of exosome-based tests and assays. Indeed, an exosomes approach represents the opportunity to expand and develop the liquid biopsy market, a growing sector in cancer diagnostics.

This report also highlights developments in therapeutics and drug development sectors. There is a significant potential for using exosome depletion as a way of treating disease; cancer-generated exosomes can inhibit the immune response and stimulate angiogenesis, the development of new blood vessels. Consequently, if these exosomes are removed, tumor growth might be inhibited, and anticancer agents can work more efficiently.

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3186718-exosome-diagnostics-and-therapeutics-global-markets

In addition, there is a potential for exosomes to be used as targeted delivery vehicles of therapeutic molecules to cancer cells; for example, delivering small interfering RNA-specific molecules (siRNA) for a particular oncogene expressed in a tumor cell.

Life science tool companies develop unique research tools for exosome detection and isolation. Current products offered in this area of industry are discussed in this report.

Although many scientific questions still need to be answered, exosomes serve as a novel and unique platform in the diagnostics and therapeutic sectors. Altogether, exosomes offer a new alternative to current diagnostics and drug development technologies.Report Scope

This report represents a current and important business tool to evaluate new commercial opportunities in the exosome diagnostic, therapeutic and research tools markets. The geographic scope of this study covers the U.S. and companies worldwide. This market is complex and consists of a number of different sectors, each affected differently by scientific and technological development. The report identifies the main positive and negative factors in each sector and forecasts further trends and product and assay development in every category of this industry.

Report Includes

– 35 data tables and 35 additional tables 
– An overview of the global markets and related technologies for exosome diagnostics and therapeutics 
– Analyses of global market trends, with data from 2016 to 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023 
– Breakdowns of new and existing diagnostic methods 
– Evaluations of current therapeutics and those likely to be utilized in the near future 
– Analyses of the market’s dynamics, specifically growth drivers, restraints, and opportunities 
– Company profiles of major players in the market, including Codiak BioSciences, Evox Therapeutics, Exosome Diagnostics, Inc., HansaBioMed, NonosomiX, Inc. and System Biosciences (SBI)CODIAK BIOSCIENCES 
EVOX THERAPEUTICS LTD. 
EXOSOME DIAGNOSTICS INC. 
HANSABIOMED LIFE SCIENCES LTD. (LONZA) 
NANOSOMIX INC. 
SYSTEM BIOSCIENCES (SBI)

Leave a Query @ https://www.wiseguyreports.com/enquiry/3186718-exosome-diagnostics-and-therapeutics-global-markets

Table of Contents 

Chapter 1 Introduction 
Study Goals and Objectives 
Reasons for Doing This Study 
Scope of Report 
Information Sources and Methodology 
Intended Audience 
Analyst's Credentials 
Related BCC Research Reports 
Chapter 2 Summary and Highlights 
Chapter 3 Market and Technology Background 
Chapter 4 Exosome Diagnostics Market 
Chapter 5 Exosome Therapeutic Market 
Chapter 6 Exosome Reagents and Research Tools Market 
Market Overview 
Isolation Methodologies and Reagents for Exosome 
Detection Methodologies and Reagents for Exosome Research 
Characterization Methods and Reagents for Exosome Research 
Engineering Methods and Reagents for Exosome Research 
Additional Products and Reagents for Exosome Research 
Market Participants for Reagents and Tools for Exosome Research 
101Bio 
AMSBIO 
Cell Guidance Systems 
Ciloa 
Evomic Science 
Excytex 
ExoCan 
HansaBiomed (Lonza) 
IZON Science 
NanoSight (Malvern Instruments) 
Nanoview Biosciences 
System Biosciences (SBI) 
Additional Market Participants for Reagents and Tools for Exosome Research 
Evaluation of Current Tools and Reagents Sector in the Exosome Market 
Chapter 7 Impact of Exosome Research on Specific Biopharmaceuticals Market 
Chapter 8 Patent Review/ New Developments 
Chapter 9 Market Summary 
Chapter 10 Company Profiles 
CODIAK BIOSCIENCES 
EVOX THERAPEUTICS LTD. 
EXOSOME DIAGNOSTICS INC. 
HANSABIOMED LIFE SCIENCES LTD. (LONZA) 
NANOSOMIX INC. 
SYSTEM BIOSCIENCES (SBI)List of Tables 

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3186718

Continued…                       

 

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Neurosurgery Software Market Major Manufacturers, Trends, Demand, Share Analysis to 2025

Neurosurgery Software Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025

PUNE, INDIA, May 22, 2018 /EINPresswire.com/ — Neurosurgery Software Market 2018

Wiseguyreports.Com adds “Neurosurgery Software Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.

Report Details:

This report provides in depth study of “Neurosurgery Software Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Neurosurgery Software Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This report studies the global Neurosurgery Software market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Neurosurgery Software market by companies, region, type and end-use industry.

This report focuses on the global top players, covered 
Renishaw (UK) 
EMS Biomedical (Austria) 
Shimmer (Ireland) 
Brainlab (Germany) 
Stryker (USA) 
Inomed Medizintechnik (Germany) 
ELMIKO Medical Equipment (Poland) 
Touch Surgery (USA) 
NORAXON (USA) 
Scopis (Germany) 
Lode (Netherlands) 
Nextech (USA) 
MEVIS Informatica Medica (Brasil) 
Compumedics (Australia) 
DX-Systems (Ukraine) 
Monteris Medical (USA) 
Dr. Grossegger & Drbal (Austria) 
Micromar (Brazil) 
Synaptive Medical (Canada)

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3163654-global-neurosurgery-software-market-size-status-and-forecast-2025

Market segment by Regions/Countries, this report covers 
United States 
Europe 
China 
Japan 
Southeast Asia 
India

Market segment by Type, the product can be split into 
Preoperative Planning Software 
Recording Software 
Visualization Software 
Analysis Software 
Others

Market segment by Application, Neurosurgery Software can be split into 
Functional Neurosurgery 
Endoscopic Surgery 
Open Skull Surgery

Key Stakeholders 
Neurosurgery Software Manufacturers 
Neurosurgery Software Distributors/Traders/Wholesalers 
Neurosurgery Software Subcomponent Manufacturers 
Industry Association 
Downstream Vendors

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@ https://www.wiseguyreports.com/reports/3163654-global-neurosurgery-software-market-size-status-and-forecast-2025

Major Key Points in Table of Content:

Global Neurosurgery Software Market Size, Status and Forecast 2025 
1 Industry Overview of Neurosurgery Software 
1.1 Neurosurgery Software Market Overview 
1.1.1 Neurosurgery Software Product Scope 
1.1.2 Market Status and Outlook 
1.2 Global Neurosurgery Software Market Size and Analysis by Regions (2013-2018) 
1.2.1 United States 
1.2.2 Europe 
1.2.3 China 
1.2.4 Japan 
1.2.5 Southeast Asia 
1.2.6 India 
1.3 Neurosurgery Software Market by Type 
1.3.1 Preoperative Planning Software 
1.3.2 Recording Software 
1.3.3 Visualization Software 
1.3.4 Analysis Software 
1.3.5 Others 
1.4 Neurosurgery Software Market by End Users/Application 
1.4.1 Functional Neurosurgery 
1.4.2 Endoscopic Surgery 
1.4.3 Open Skull Surgery

2 Global Neurosurgery Software Competition Analysis by Players 
2.1 Neurosurgery Software Market Size (Value) by Players (2013-2018) 
2.2 Competitive Status and Trend 
2.2.1 Market Concentration Rate 
2.2.2 Product/Service Differences 
2.2.3 New Entrants 
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles 
3.1 Renishaw (UK) 
3.1.1 Company Profile 
3.1.2 Main Business/Business Overview 
3.1.3 Products, Services and Solutions 
3.1.4 Neurosurgery Software Revenue (Million USD) (2013-2018) 
3.2 EMS Biomedical (Austria) 
3.2.1 Company Profile 
3.2.2 Main Business/Business Overview 
3.2.3 Products, Services and Solutions 
3.2.4 Neurosurgery Software Revenue (Million USD) (2013-2018) 
3.3 Shimmer (Ireland) 
3.3.1 Company Profile 
3.3.2 Main Business/Business Overview 
3.3.3 Products, Services and Solutions 
3.3.4 Neurosurgery Software Revenue (Million USD) (2013-2018) 
3.4 Brainlab (Germany) 
3.4.1 Company Profile 
3.4.2 Main Business/Business Overview 
3.4.3 Products, Services and Solutions 
3.4.4 Neurosurgery Software Revenue (Million USD) (2013-2018) 
3.5 Stryker (USA) 
3.5.1 Company Profile 
3.5.2 Main Business/Business Overview 
3.5.3 Products, Services and Solutions 
3.5.4 Neurosurgery Software Revenue (Million USD) (2013-2018) 
3.6 Inomed Medizintechnik (Germany) 
3.6.1 Company Profile 
3.6.2 Main Business/Business Overview 
3.6.3 Products, Services and Solutions 
3.6.4 Neurosurgery Software Revenue (Million USD) (2013-2018) 
3.7 ELMIKO Medical Equipment (Poland) 
3.7.1 Company Profile 
3.7.2 Main Business/Business Overview 
3.7.3 Products, Services and Solutions 
3.7.4 Neurosurgery Software Revenue (Million USD) (2013-2018) 
3.8 Touch Surgery (USA) 
3.8.1 Company Profile 
3.8.2 Main Business/Business Overview 
3.8.3 Products, Services and Solutions 
3.8.4 Neurosurgery Software Revenue (Million USD) (2013-2018) 
3.9 NORAXON (USA) 
3.9.1 Company Profile 
3.9.2 Main Business/Business Overview 
3.9.3 Products, Services and Solutions 
3.9.4 Neurosurgery Software Revenue (Million USD) (2013-2018) 
3.10 Scopis (Germany) 
3.10.1 Company Profile 
3.10.2 Main Business/Business Overview 
3.10.3 Products, Services and Solutions 
3.10.4 Neurosurgery Software Revenue (Million USD) (2013-2018) 

Continued….

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Travelers Vaccines Market 2018- Global Industry Analysis, By Key Players, Segmentation, Trends And Forecast By 2025

Travelers Vaccines – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2025

PUNE, MAHARASHTRA, INDIA, May 22, 2018 /EINPresswire.com/ — Travelers Vaccines Market 2018

Wiseguyreports.Com Adds “Travelers Vaccines – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.

Description: 

This report studies the global Travelers Vaccines market status and forecast, categorizes the global Travelers Vaccines market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

In 2017, the global Travelers Vaccines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx.x % between 2018 and 2025.

The major manufacturers covered in this report 
GSK 
Sanofi Pasteur 
Pfizer 
Merck 
Sanofi Pasteur MSD 
CNBG 
Biokangtai 

Request for Sample Report@ https://www.wiseguyreports.com/sample-request/3175932-global-travelers-vaccines-market-research-report-2018

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering 
North America 
Europe 
Asia-Pacific 
South America 
Middle East & Africa

The regional scope of the study is as follows: 
North America 
United States 
Canada 
Mexico 
Asia-Pacific 
China 
India 
Japan 
South Korea 
Australia 
Indonesia 
Singapore 
Rest of Asia-Pacific 
Europe 
Germany 
France 
UK 
Italy 
Spain 
Russia 
Rest of Europe 
Central & South America 
Brazil 
Argentina 
Rest of South America 
Middle East & Africa 
Saudi Arabia 
Turkey 
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into 
Meningococcal Vaccine 
Japanese Encephalitis Vaccine 
Rabies Vaccine 
Typhoid Vaccine 
Yellow Fever Vaccine 
Hepatitis B Vaccine 
Hepatitis A Vaccine 
Cholera Vaccine 
Other Vaccines 
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including 
Tourists 
Students 
Workers 
Others

Enquiry before Buying @ https://www.wiseguyreports.com/enquiry/3175932-global-travelers-vaccines-market-research-report-2018

If you have any special requirements, please let us know and we will offer you the report as you want.

Table Of Content:

Global Travelers Vaccines Market Research Report 2018 
1 Travelers Vaccines Market Overview 
1.1 Product Overview and Scope of Travelers Vaccines 
1.2 Travelers Vaccines Segment by Type (Product Category) 
1.2.1 Global Travelers Vaccines Production and CAGR (%) Comparison by Type (Product Category)(2013-2025) 
1.2.2 Global Travelers Vaccines Production Market Share by Type (Product Category) in 2017 
1.2.3 Meningococcal Vaccine 
1.2.4 Japanese Encephalitis Vaccine 
1.2.5 Rabies Vaccine 
1.2.6 Typhoid Vaccine 
1.2.7 Yellow Fever Vaccine 
1.2.8 Hepatitis B Vaccine 
1.2.9 Hepatitis A Vaccine 
1.2.10 Cholera Vaccine 
1.2.11 Other Vaccines 
1.3 Global Travelers Vaccines Segment by Application 
1.3.1 Travelers Vaccines Consumption (Sales) Comparison by Application (2013-2025) 
1.3.2 Tourists 
1.3.3 Students 
1.3.4 Workers 
1.3.5 Others 
1.4 Global Travelers Vaccines Market by Region (2013-2025) 
1.4.1 Global Travelers Vaccines Market Size (Value) and CAGR (%) Comparison by Region (2013-2025) 
1.4.2 North America Status and Prospect (2013-2025) 
1.4.3 Europe Status and Prospect (2013-2025) 
1.4.4 Asia-Pacific Status and Prospect (2013-2025) 
1.4.5 South America Status and Prospect (2013-2025) 
1.4.6 Middle East & Africa Status and Prospect (2013-2025) 
1.5 Global Market Size (Value) of Travelers Vaccines (2013-2025) 
1.5.1 Global Travelers Vaccines Revenue Status and Outlook (2013-2025) 
1.5.2 Global Travelers Vaccines Capacity, Production Status and Outlook (2013-2025)

……..

7 Global Travelers Vaccines Manufacturers Profiles/Analysis 
7.1 GSK 
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.1.2 Travelers Vaccines Product Category, Application and Specification 
7.1.2.1 Product A 
7.1.2.2 Product B 
7.1.3 GSK Travelers Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.1.4 Main Business/Business Overview 
7.2 Sanofi Pasteur 
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.2.2 Travelers Vaccines Product Category, Application and Specification 
7.2.2.1 Product A 
7.2.2.2 Product B 
7.2.3 Sanofi Pasteur Travelers Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.2.4 Main Business/Business Overview 
7.3 Pfizer 
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.3.2 Travelers Vaccines Product Category, Application and Specification 
7.3.2.1 Product A 
7.3.2.2 Product B 
7.3.3 Pfizer Travelers Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.3.4 Main Business/Business Overview 
7.4 Merck 
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.4.2 Travelers Vaccines Product Category, Application and Specification 
7.4.2.1 Product A 
7.4.2.2 Product B 
7.4.3 Merck Travelers Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.4.4 Main Business/Business Overview 
7.5 Sanofi Pasteur MSD 
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.5.2 Travelers Vaccines Product Category, Application and Specification 
7.5.2.1 Product A 
7.5.2.2 Product B 
7.5.3 Sanofi Pasteur MSD Travelers Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.5.4 Main Business/Business Overview 
7.6 CNBG 
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.6.2 Travelers Vaccines Product Category, Application and Specification 
7.6.2.1 Product A 
7.6.2.2 Product B 
7.6.3 CNBG Travelers Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.6.4 Main Business/Business Overview 
7.7 Biokangtai 
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.7.2 Travelers Vaccines Product Category, Application and Specification 
7.7.2.1 Product A 
7.7.2.2 Product B 
7.7.3 Biokangtai Travelers Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.7.4 Main Business/Business Overview 

Continued…..

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Innovative Risk Score Tool Effectively Predicts Future Risk of Hospitalization for Pulmonary Disease Patients

Researchers have developed a new tool that utilizes basic laboratory tests to effectively identify patients with chronic obstructive pulmonary disease who are at high risk of being hospitalized due to a flare up of the condition.

Because the LIVE score is laboratory-based and reproducible, we are able to calculate the LIVE score electronically and identify high risk patients at the time of contact.”

— Denitza Blagev, MD, Intermountain Medical Center

SALT LAKE CITY, UT, USA, May 22, 2018 /EINPresswire.com/ — Researchers have developed a new tool that utilizes basic laboratory tests to effectively identify patients with chronic obstructive pulmonary disease who are at high risk of being hospitalized due to a flare up of the condition.

The new risk-score stratification tool, developed and validated in more than 132,000 patient records by Intermountain Healthcare researchers at Intermountain Medical Center in Salt Lake City, is unique in that it uses laboratory tests used in routine care to determine whether patients are at high or low risk of hospital admission in real time.

Researchers say the new Laboratory-based Intermountain Validated Exacerbation tool, known as the LIVE Score, may help clinicians better care for COPD patients by predicting high-risk patients who may benefit from early and specific interventions to avoid hospitalization.

COPD is the name for a group of diseases, primarily emphysema and chronic bronchitis, that are chronic inflammatory lung diseases that cause obstructed airflow from the lungs that affect more than 15 millions Americans, according to the Centers for Disease Control and Prevention.

Acute exacerbation of COPD is a sudden worsening of COPD symptoms (shortness of breath, quantity and color of phlegm) that typically lasts for several days, and in severe situations can lead to hospitalization. Symptoms can be exacerbated, or worsened, by airborne irritants like secondhand smoke, dust, pollen, fumes or air pollution. During a flare up, patients may end up in their doctor’s office, the emergency department, or require hospitalization.

In the retrospective study, researchers found the majority of patients who experienced COPD exacerbations were in the LIVE risk-score model’s two highest risk groups. Conversely, patients in the risk model’s lowest risk group, fewer patients had exacerbations.

“We believe the ability to effectively identify these patients and intervene earlier in the course of a COPD exacerbation may help provide them with a higher quality of life, and potentially reduce medical costs associated with preventable hospital admissions,” said principal investigator Denitza Blagev, MD, a pulmonary and critical care physician at Intermountain Medical Center and medical director for quality for Intermountain Healthcare.

Results of the study of the LIVE Score model was be presented this week at the American Thoracic Society’s annual international conference in San Diego.

The LIVE risk score was validated among 48,871 patients who received a COPD diagnosis at Intermountain Healthcare between 2009 and 2016, and later validated among 83,134 patient records from the Veterans Affairs National Health System. Researchers from the University of California, San Francisco, and the VA Medical Center in San Francisco participated in the study.

At first, COPD may cause no symptoms or only mild symptoms. As the disease gets worse, symptoms usually become more severe. They include: a cough that produces mucus, shortness of breath (specially with physical activity), wheezing, and chest tightness.

There is currently no cure for COPD, but treatments are available to manage the symptoms and include: medications (such as inhalers), pulmonary rehabilitation, physical activity training, and oxygen treatments.

“Although we currently think about COPD as a single disease, the course and progression of the disease is variable among patients,” said Dr. Blagev. “It’s not only based on the severity of their COPD and lung function, but also on the number and variety of other medical problems a patient may have.”

The new LIVE scoring tool allows for improved COPD patient care on a health system level by identifying when earlier interventions may prove useful, while educating patients and families on what the future may look like for an individual patient diagnosed with COPD.

Dr. Blagev said further study is needed to examine the utility of the LIVE Score as a population health strategy in COPD patients. But she is encouraged by initial findings.

“Because the LIVE score is laboratory based and reproducible, we are able to calculate the LIVE score electronically and identify high risk patients at the time of contact,” she noted. “We can also identify patients based on data previously collected, even if they are not in the hospital currently, and can begin to develop interventions targeting these highest risk patients.”

Other members of the research team involved in the study include: Dave S. Collingridge, PhD and Susan Rea, PhD, with Intermountain Healthcare, and Siyang Zeng, MS and Mehrdad Arjomandi, MD, with University of California, San Francisco (UCSF) and the San Francisco Veterans Affairs Medical Center.

Intermountain Medical Center is the flagship facility for the Intermountain Healthcare system, which is based in Salt Lake City.
###

Jess Gomez
Intermountain Medical Center
801-507-7455
email us here


Source: EIN Presswire

Arizona Mesothelioma Victims Center Now Urges a Navy Veteran with Mesothelioma in Arizona to Call for Direct Access to the Nation's Top Attorneys Who Will Get Better Financial Compensation Results

Hiring a local car-accident attorney to handle a mesothelioma compensation claim could result in a navy veteran with mesothelioma getting dramatically shortchanged-overcharged or both”

— Arizona Mesothelioma Victims Center

NEW YORK, NEW YORK, USA, May 22, 2018 /EINPresswire.com/ — The Arizona Mesothelioma Victims Center is urging a US Navy Veteran who has been recently diagnosed with mesothelioma, or their family to please call them anytime at 800-714-0303 so they do not mistakenly hire an inexperienced lawyer/law firm. If a Navy Veteran with mesothelioma wants the very best mesothelioma financial compensation they need direct access to some of the nation's most skilled mesothelioma attorneys who exclusively handle mesothelioma compensation claims on a full-time basis. The mesothelioma lawyers the group suggests frequently get million-dollar settlements for Navy Veterans with mesothelioma-especially if the Veteran was exposed to asbestos in a ship's engine room or by working on a submarine's nuclear reactor. http://Arizona.MesotheliomaVictimsCenter.Com

According to the group, "When it comes to mesothelioma compensation for a US Navy Veteran, it is incredibly vital the attorney you hire has years of experience with Navy Veteran asbestos exposure cases. Hiring a local car-accident attorney or personal-injury attorneys to handle a mesothelioma compensation claim could result in a navy veteran with mesothelioma getting dramatically shortchanged-overcharged or both as we would like to discuss anytime at 800-714-0303.” http://Arizona.MesotheliomaVictimsCenter.Com

The Arizona Mesothelioma Victims Center has experience helping US Navy Veterans who were exposed to asbestos on the following types of US Navy ships:

* Destroyers
* Frigates
* Air Craft Carriers (Essex & Nimitz Class)
* Cruisers
* Fast Attack Submarines (Los Angeles Class)
* Boomers (Ohio Class Submarine)
* Amphibious Assault Ships (Tarawa Class)
* Oilers and Cargo Ships
* Navy Tugs/Support Vessels

For a listing of all former and current US Navy ships, please refer to the US Navy's website that addresses these topics. http://www.navy.mil/ navydata/our_ships.asp

For the best possible mesothelioma treatment options in Arizona the Arizona Mesothelioma Victims Center strongly recommends the following heath care facilities with the offer to help a diagnosed victim, or their family get to the right physicians at each hospital.

* The Mayo Clinic Phoenix/Scottsdale, Arizona: http://www.mayoclinic.org/departments-centers/mayo-clinic-cancer-center

* The University of Arizona Medical Center Tucson, Arizona:
http://azcc.arizona.edu/profile/linda-garland.

The Arizona Mesothelioma Victims Center would like to emphasize theirs is a statewide initiative available to a diagnosed victim anywhere in Arizona including communities such as Phoenix, Tucson, Mesa, Chandler, Glendale, Gilbert, Tempe. Peoria, or Prescott. http://Arizona.MesotheliomaVictimsCenter.Com

High-risk work groups for exposure to asbestos in Arizona include US Navy Veterans, power plant workers, manufacturing workers, plumbers, nuclear power plant workers, electricians, auto mechanics, machinists, or construction workers. Typically, these high-risk workers were exposed to asbestos in the 1950’s, 1960’s, 1970’s, or 1980’s.

The states indicated with the highest incidence of mesothelioma include Maine, Massachusetts, Connecticut, Maryland, New Jersey, Pennsylvania, Ohio, West Virginia, Virginia, Michigan, Illinois, Minnesota, Louisiana, Washington, and Oregon. Mesothelioma also happens in Arizona. http://Arizona.MesotheliomaVictimsCenter.com

The Mesothelioma Victims Center is a national advocate 100% focused in on doing everything possible to ensure people with mesothelioma in every state receive the best possible financial compensation settlement. The group offers on the spot access to some of the nation’s most skilled and experienced mesothelioma attorneys because to receive the very best possible financial compensation a diagnosed person must be represented by the most capable mesothelioma lawyers in the United States as they would like to discuss at 800-714-0303. http://MesotheliomaVictimsCenter.Com

For more information about mesothelioma please refer to the National Institutes of Health’s web site related to this rare form of cancer: https://www.cancer.gov/types/mesothelioma

Michael Thomas
Arizona Mesothelioma Victims Center
800-714-0303
email us here


Source: EIN Presswire

Smart Medical Devices Market Opportunities by Key Players, Regional Segmentation and Forecasts, 2018 – 2023

PUNE, MAHARASHTRA, INDIA, May 22, 2018 /EINPresswire.com/ — Global Smart Medical Devices Industry

New Study on “2018-2023 Smart Medical Devices Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” added to Wise Guy Reports Database

A smart medical device is an appliance; software, used for variety of therapeutic and diagnostic purposes. It has been used in a wide range of applications such as monitoring heart rate; glucose monitoring; pain relief; insulin delivery; and so forth. Smartphones play a significant role in operating these smart medical devices in the healthcare sector. The increasing adoption of smartphones across the globe, coupled with rising demand for the medical devices compatible with smartphones are major driving factors that are augmenting the growth of the global smart medical devices market. The market has been analyzed on the basis of product type, test type, and end users.

Try Sample Report @    https://www.wiseguyreports.com/sample-request/3186878-global-smart-medical-devices-market-research-and-forecast-2018-2023

Moreover, rising geriatric population is another factor fueling the market. There is an increased demand for smart medical devices due to growing geriatric population since elderly people are prone to chronic diseases such as CVD, Cancer and Diabetes. Major players are launching new products coupled with the advancement in the technologies to further accelerate the growth of the global smart medical devices market. Apart from these, rising population in the emerging economies and improvement in lifestyle standards of the people along with increasing disposable income will show a lucrative growth in the market during the forecast period. However, there are certain factors such as high cost of medical devices; and security and privacy concerns of the patients (for example: personal data of the patients can be hacked) are hampering the growth of the market.

Based on the region, the global smart medical devices market has been divided into North America, Europe, Asia Pacific and Rest of the World. North America dominates the global smart medical devices market owing to well-developed healthcare infrastructure and increasing advancement in technologies. APAC region is anticipated to be fastest growing market due to increasing population and rising disposable incomes.

The companies contributing to the growth of global smart medical devices market include Abbott Laboratories, Johnson & Johnson Ltd., Fitbit Inc., Dexcom Inc., Medtronic plc, NeuroMetrix Inc., Olympus Medical systems and many more. Majority of key players are focusing on partnership, collaboration and merger and acquisition to gain a competitive edge over others and enhance their presence. For instance, in January 2015, Medtronic completed its acquisition of Covidien. This acquisition was aimed at the expansion of its product portfolio resulting in the increased market penetration and reduced production cost.

Research Methodology

The market study of smart medical devices market is incorporated by extensive primary and secondary research conducted by research team at OMR Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The OMR team collects facts and data related to the market from different geographies to provide a better regional outlook. In the report, country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. The numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analysts to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts to get first-hand information. Primary research brings authenticity to our reports.

Secondary sources include:

Financial reports of companies involved in the market 
Whitepapers, research-papers and news blogs 
Company websites and their product catalogue 

The report is intended for hospitals, medical device manufacturers, diagnostic centers, government and private organizations for the overall market analysis and competitive analysis. The report provides in-depth analysis on pricing, market size, and intended quality of the product preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models such as PEST analysis delivering insights into the market for better business decisions.

Market Segmentation:

Global smart medical devices market by product type 
Global smart medical devices market by test type 
Global smart medical devices market by end users 
The Report covers:

Comprehensive research methodology of Global Smart Medical Devices Market. 
This report also includes detailed and extensive market overview with Analyst insights & key market trends. 
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations. 
Analysis of regional regulations and other government policies impacting the Global Smart Medical Devices Market. 
Insights about market determinants which are stimulating the Global Smart Medical Devices Market. 
Detailed and extensive market segments with regional distribution of forecasted revenues. 
Extensive profiles and recent developments of market players.

 Some points from table of content:

CHAPTER 1. REPORT SUMMARY 
1.1. RESEARCH METHODS AND TOOLS 
1.2. MARKET BREAKDOWN 
1.2.1. BY SEGMENTS 
1.2.2. BY GEOGRAPHY 
1.2.3. BY STAKEHOLDERS 
CHAPTER 2. MARKET OVERVIEW AND INSIGHTS 
2.1. DEFINITION 
2.2. ANALYST INSIGHTS &CURRENT MARKET TRENDS 
2.2.1. KEY FINDINGS 
2.2.2. RECOMMENDATION 
2.2.3. CONCLUSION 
2.3. REGULATIONS 
2.3.1. UNITED STATES 
2.3.2. EUROPEAN UNION 
2.3.3. CHINA 
2.3.4. INDIA 
2.3.5. REST OF THE WORLD 

For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3186878-global-smart-medical-devices-market-research-and-forecast-2018-2023

CHAPTER 3. MARKET DETERMINANT 
3.1. MOTIVATORS 
3.1.1. INCREASING ADOPTION OF SMARTPHONES AND SMARTPHONE COMPATIBLE DEVICES 
3.1.2. RISING DEMAND FOR BETTER CONVENIENCE AND FLEXIBLE HEALTHCARE DEVICES AMONG GERIATRIC POPULATION 
3.1.3. INCREASING HEALTHCARE EXPENDITURE 
3.1.4. TECHNOLOGICAL ADVANCEMENT SUCH AS EVOLUTION OF SMART SCALPELS AND SMART PROBES 
3.1.5. RISING TREND OF REMOTE HEALTH MONITORING 
3.2. RESTRAINTS 
3.2.1. HIGH COSTS OF SMART MEDICAL DEVICES 
3.2.2. PATIENT’S PRIVACY CONCERNS MAY AFFECT MARKET GROWTH 
3.3. OPPORTUNITIES 
3.3.1. INCREASING INVESTMENT IN EMERGING ECONOMIES FOR SMART MEDICAL DEVICES 
3.3.2. RISING AWARENESS TOWARDS SMART MEDICAL DEVICES 
3.3.3. RISING NUMBER OF MARKET PLAYERS WITH A BROADER PRODUCT PORTFOLIO 
CHAPTER 4. MARKET SEGMENTATION 
4.1. GLOBAL SMART MEDICAL DEVICES MARKET BY PRODUCT TYPE 

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

True Protein unveils new Sample Box collection

Find the flavour that’s right for you with True Protein’s four new Sample Box packs including bestsellers Pro Define, Vegan 85, WPC 80 and WPI 90 blends.

SYDNEY, NEW SOUTH WALES, AUSTRALIA, May 22, 2018 /EINPresswire.com/ — Featuring a slick box design for neat storage, each protein blend is made from 100% natural ingredients and contains all 9 essential amino acids, including BCAAs, in up to 14 delicious flavours.

Designed to give consumer’s the chance to try True Protein’s full range of flavours and find their favourite, the convenient individual sachets are also perfect for a trip away or for protein on the go, starting from just $24 per box. All Sample Boxes also come with a free protein shaker.

The Sample Box collection includes:

WPI 90 Sample Box, RRP $30
14 sachets (1 x French Vanilla, 1 x Rich Chocolate, 1 x Coffee Mocha, 1 x Salted Caramel, 1 x Apple & Cinnamon, 1 x Natural, 1 x Choc Mint, 1 x Strawberries & Cream, 1 x Choc Peanut Butter, 1 x Iced Chai, 1 x Pina Colada, 1 x Lemon Cake, 1 x Raw Coconut, 1 x Banana & Honey) + free large shaker

Blended with New Zealand grass-fed whey protein isolate and natural flavourings for a premium taste, WPI 90 is an excellent choice for lean muscle development and weight management.

WPC 80 Sample Box, RRP $24
14 sachets (1 x French Vanilla, 1 x Rich Chocolate, 1 x Coffee Mocha, 1 x Salted Caramel, 1 x Apple & Cinnamon, 1 x Natural, 1 x Choc Mint, 1 x Strawberries & Cream, 1 x Choc Peanut Butter, 1 x Iced Chai, 1 x Pina Colada, 1 x Lemon Cake, 1 x Raw Coconut, 1 x Banana & Honey) + free large shaker

WPC 80 is a fast digesting New Zealand-sourced whey protein concentrate powder with an exceptional amino acid profile perfect for assisting with post-workout recovery and supporting lean muscle growth.

Pro Define Sample Box, RRP $30
12 sachets (3 x French Vanilla, 3 x Rich Chocolate, 3 x Banana & Honey, 3 x Raw Coconut) + free Small Shaker

This premium weight loss supplement contains a complete protein blend as well as key additions of carnitine, green tea extract and coconut water powder.

Vegan 85 Sample Box, RRP $24
12 sachets (2 x French Vanilla, 2 x Rich Chocolate, 2 x Coffee Mocha, 2 x Salted Caramel, 2 x Apple & Cinnamon, 2 x Natural) + free small shaker

A unique blend of Belgium-sourced pea protein and organic US-sourced brown rice protein, Vegan 85 contains 85% protein content in a completely natural form, derived from 100% plant-based sources.

ENDS

Note to Editors
For more information, high res imagery or to try the sample packs please contact PR & Communications Officer Natalie Crofts on nataliecrofts@trueprotein.com.au.
True Protein also has an in-house accredited sports dietitian available for expert comment on request.
For more information on the full range, visit www.trueprotein.com.au.
1300 536 688

About True Protein
Founded in 2013 by Australian brothers James and Ben Kierath, True Protein offers a unique range of sports supplements boasting high quality, all-natural ingredients and a premium flavour.
Fed up with expensive, poor tasting protein powders packed with additives and artificial ingredients, the Kierath’s decided it was time for a change. Seeking to push the limits of an already saturated sports supplements market, the brothers had the idea for a clean, great tasting protein made using 100% natural ingredients, maximum purity amino acids and healthy antioxidants. No additives, no fillers, no artificial flavourings, no artificial sweeteners, and no artificial aftertaste.
True Protein promotes a full disclosure, total honesty policy for their entire range, which now consists of 40 individual sports supplement products, including vegan and weight loss proteins. Made with health in mind, the supplements feature non-GMO, organic, grass-fed ingredients wherever possible, sourced from all corners of the globe.

Natalie Crofts
True Protein
1300 536 688
email us here


Source: EIN Presswire

Indiana Whistleblower Center Now Urges a Physical Therapist in Indiana to Call About Rewards If They Can Prove Their Employer Is Overbilling Medicare for Unauthorized or Unsupervised PT Sessions

We believe one of the easiest ways to rip off Medicare is with unsupervised or unauthorized physical therapy on the part of a healthcare company."”

— Indiana Corporate Whistleblower Center

WASHINGTON, DC, USA, May 22, 2018 /EINPresswire.com/ — The Indiana Corporate Whistleblower Center is urging a physical therapist, a healthcare manager or medical doctor in Indiana to call them at 866-714-6466 if they have proof a healthcare company is involved in a scheme to gouge Medicare, Medicaid or TRICARE with unauthorized high volume physical therapy that was not being supervised by a physician.

According to the group, "We believe one of the easiest ways to rip off Medicare is with unsupervised or unauthorized physical therapy on the part of a healthcare company, and we are confident there are bad actors in every state involved in high volume overbilling of Medicare using PT as the excuse. Recently a whistleblower received $225,000 for this exact type of information."
http://Indiana.CorporateWhistleblower.Com

In January 2018 the Department of Justice announced a health care system based in Southern California agreed to pay $1.5 million to resolve allegations that it violated the False Claims Act by billing Medicare and TRICARE for physical therapy services provided by therapists without billing privileges and without the appropriate supervision by a physician. The whistleblower reward for this wrongdoing was $225,000 as mentioned.

Aside from therapists or physicians with proof a healthcare company is gouging Medicare with unsupervised or unauthorized physical therapy the Indiana Corporate Whistleblower Center would like to hear from the following types of people:

* A nursing home employee who can prove their employer is billing Medicare as if the facility is fully staffed when the opposite is true—the facility is constantly short staffed and patients are at risk.

* An employee at a rehab center, a skilled nursing facility, a dialysis center, a company providing hospice services, an imaging center, a blood testing company, or a hospital ER physician who can prove their Indiana based employer is billing Medicare/Medicaid for services never rendered or for unnecessary medical procedures.

The Indiana Corporate Whistleblower Center says, "If you are a Medical Doctor or any type of healthcare worker in Indiana and you have significant proof a healthcare provider is gouging Medicare or Medicaid with bills for services that never happened or for medical services that should have never taken place please call us anytime at 866-714-6466 so we can discuss the value of the potential whistleblower reward. Why sit on what could be a winning lotto ticket without ever knowing what it might have been worth?”
http://Indiana.CorporateWhistleblower.Com

Simple rules for a whistleblower from the Indiana Corporate Whistleblower Center: Do not go to the government first if you are a potential whistleblower with substantial proof of wrongdoing. The Indiana Corporate Whistleblower Center says, “Major whistleblowers frequently go to the government thinking they will help. It’s a huge mistake. Do not go to the news media with your whistleblower information. Public revelation of a whistleblower’s information could destroy any prospect for a reward. Do not try to force a company/employer or individual to come clean about significant Medicare fraud, overbilling the federal government for services never rendered, multi million dollar state or federal tax evasion, or a Indiana based company falsely claiming to be a minority owned business to get preferential treatment on federal or state projects. Come to us first, tell us what type of information you have, and if we think it’s sufficient, we will help you with a focus on you getting rewarded.”

Unlike any group in the US the Corporate Whistleblower Center can assist a potential whistleblower with packaging or building out their information to potentially increase the reward potential. They will also provide the whistleblower with access to some of the most skilled whistleblower attorneys in the nation. For more information a possible whistleblower with substantial proof of wrongdoing in Indiana can contact the Whistleblower Center at 866-714-6466 or contact them via their website at http://Indiana.CorporateWhistleBlower.Com

For attribution please refer to the January 2018 Department of Justice announcement about this whistleblower reward. https://www.justice.gov/opa/pr/scripps-health-pay-15-million-settle-claims-services-rendered-unauthorized-physical

Thomas Martin
Indiana Corporate Whistleblower Center
866-714-6466
email us here


Source: EIN Presswire

Tahoe Group is transforming China’s healthcare into a global, high-tech industry

Tahoe donated RMB 100million yuan to China Organ Transplantation Development Foundation

Tahoe introduced cutting-edge facilities and international medical experts to China

Tahoe Healthcare reached cooperation with UPMC

IRVINE, CALIFORNIA, THE UNITED STATES, May 21, 2018 /EINPresswire.com/ — China’s expanding, and aging, middle-class presents great opportunities for the healthcare industry and its development through private investment and cooperation. China’s Tahoe Group is moving quickly to bring in foreign expertise, ink cooperation deals with major research and teaching colleges, as well as build a portfolio of modern hospitals.

A new healthcare strategy for an aging population

While the world’s manufacturer shows no slowing in its ascent up the value chain,one service industry stands out as highly profitable, international business in need of development and innovation: healthcare.

China’s incredible economic expansion over the decades since opening and reform has been accompanied by a much documented one-child policy. Working families with a single, young dependent gave a labor-heavy boost to economic growth and brought about the rise of the nation.But an unwanted side effect was a rapidly aging society. China’s “gray tide” is bringing ever-more sophisticated healthcare demands and thus great opportunities to the domestic healthcare industry and innovations in industry partnerships and logistics.

Beijing’s current five-year economic plan, ratified in 2016, included a high-priority goal of achieving a “Healthy China” a priority. Nothing less than a world-class healthcare sector fueled by inbound private investment international cooperation is the core objective.

This ambitious national policy has attracted a big player in the form of Tahoe Group Co Ltd, moving rapidly into the healthcare sectorand investing in expansion and upgrades to China’s private health sector: hospitals, healthcare centers and medical technology.

The purchase of US-based Alliance HealthCare Services, for example, was a key strategic move for the group. It granted them access to 30 years of experience in high-quality clinical care, including services in radiology and oncology. Two healthcare centers were opened on April 22 in Fuzhou, capital of southern China’s Fujian Province, including one offering advanced facilities and therapies from Alliance, with a focus on private cancer patients. The Massachusetts General Hospital physical examination, ranking first in the US, is used at one location, the Tahoe HealthCare Center. Tumor screening will be a flagship service here, while medical experts can provide remote diagnoses and consultations.

As part of a strategy to build a portfolio of large-scale general hospitals, Tahoe purchased Beijing Yuhe Hospital in November 2016 and cooperated with Weill Cornell Medicine (the biomedical research unit and medical school of Cornell University) and Partners HealthCare International (the leading integrated academic health care system in the United States) to build and develop Yangpu International Hospital in Shanghai for servicing the local market and providing international medical facilities to expatriates.

For training the physicians and nurses of tomorrow, Tahoe Group is currently cooperating with Tsinghua Medical College (Beijing), Tongji Medical College (Wuhan), Weill Cornell Medical College (New York) and the University of Pittsburgh Medical Center.

Tahoe Group’s Chairman Huang Qisen believes the acquisition of Alliance HealthCare Services and cooperation with top international hospitals and organizations will provide cutting-edge medical technology, techniques and services to the group’s general hospitals, special hospitals and healthcare centers. China’s private sector healthcare can thus benefit the public and promote the development of the industry.

China currently lacks hospital beds for rising rates of certain diseases, such as cancer, and there is a significant gap in the market that private healthcare and international cooperation can fulfill. Currently, cancer treatment mainly takes place in public hospitals, which provide 91% of beds for patients.A spokesperson for Tahoe Group said that cancer cases in China had increased year on year, reachingsome 25% of the world’s total, due to environmental factors and life pressure.

Private care provides healthy returns on investment

As the second-largest healthcare market in the world, China is proving attractive to foreign investors. A recent report from McKinsey & Co. estimates China's healthcare market will reach USD 1 trillion by 2020.

Outside of the mixed quality of services at China’s state-run hospitals,non-governmental investment is funding private healthcare that aims to be world class. The operational framework of Tahoe Group’s medical services is a detailed insight into the future of China’s healthcare industry.

The growth of the Chinese healthcare market is expected to be driven mainly by the country’s ageing population, rise in incidences of lifestyle-related diseases such as diabetes and cancer, and major steps taken by the government to improve the local healthcare infrastructure. Recent regulatory changes by the Chinese government are expected to speed up the approvals of medicines and medical devices, thus easing the process of introducing new treatments to the market.

China’s healthcare woes in numbers

255 million
China’s population of over 60s by 2020.

4.3 million
New diagnoses of invasive cancer in 2015 in China.

138,000
Cases of lung cancer in Chinese men over 75 years old.

USD 1 trillion
The estimated value of China’s healthcare sector by 2020.

Janet Yang
BON Cloud
(+86 10) 52270888-6984
email us here

Tahoe Group is transforming China’s healthcare into a global, high-tech industry


Source: EIN Presswire

Treat Your Teen’s Drug Abuse Problem With A Reliable Rehab Center And Long-Term Treatment

American Rehab Centers, the largest network of addiction treatment centers in the world can help you to choose addiction treatment centers with affordable cost.

FLORIDA, FL, UNITED STATES, May 21, 2018 /EINPresswire.com/ — Each year thousands of people in America fall prey to the evil called drugs. With increasing rate of drug abuse, the risk of death from overdose also increases. It is no secret that teens are often the one most vulnerable to drug abuse. They are often seen abusing drugs to which the parents are completely oblivious. It is often tougher for the parents or guardians to recognize as the warning signs of teen drug abuse often appears later. However, when they come the aspect is apparent in not only physical and emotional but behavioral changes too. This is where it is essential for you to seek the help of Christian addiction treatment that can keep your kid safe. If you are wondering where to get that platform, then let us introduce you to americanrehabcenters.com.

American Rehab centers is a platform from where you can get access to the best centers across the country. It is such that helps you in finding the centers that provide you with Long-term addiction treatment.

Reading the signs:
There are many parents who are completely unaware of the warning signs that can give rise to the suspicion if their teenager is on drugs or not. The first step that you need to take is to make sure that you are properly away about the signs which will help you in stepping into the next phase at the look for their treatment at Christian rehab centers.

• Behavior change:
The first thing that you will notice is that your kid will have a sudden change in behavior. It will change their mannerism in the way they interact with their family and friends.

• Mood change:
Though teenagers are often attributed to sudden mood change, this is one aspect that you need to keep in mind. If they are too irrational or overdramatic then it is an aspect for you to worry about. Additionally, if they destroy the home or school property then you need to take help of American Rehab Centers to find about the best rehab for your kid.

• Physical changes:
It starts with small changes then grows into something bigger that can very easily spin out of control. If your teenager is under the influence of drugs then you will notice bloodshot eyes, poor hygiene, tremors, flushed cheeks, fatigue, and sudden change in weight.

• Change in personality:
If suddenly your kid seems to have poor moral or low apathy then that is a trigger sign. Though it can be a sign of adolescence a careful watch will reveal the different for a parent.

• Financial concerns:
Yes, as sad it may sound but when they are doing drugs then they are bound to run into financial issues. You may also find missing money or other items of value form your own that they might use to pay for the drugs.

Here, it is essential that the parents keep a keen eye on the kids to make sure to spot the signs early.

The task of confrontation:

It is very hard for a parent to acknowledge that their kid is having an addiction. However, without that and eventual confrontation with your teenager, it will hard to give them proper Christian addiction treatment. Here are some tips that will help:

• Keep it calm:
Knowing that your child is taking drugs will give rise to the emotions of anger and frustration. It is very important that you do not let that overpower yourself while confronting your kid, it will make matters worse.

• Understand:
Taking drugs might not always be out of fun. There are times when the teenagers are pushed to that dark alley when they are unable to control their depression or anxiety. It’s important to understand if you want to find the best Christian rehab centers for her or him.

• Talk privately:
Do not shame them in front of everyone. It is better to talk privately and alongside make sure that you are always reassuring which will certainly help during their Long-term addiction treatment.

David
American Rehab Centers
(855)934-HOPE (4673)
email us here


Source: EIN Presswire